DOCS Stock Price Today (October 2026) — Doximity, Inc. Analysis & Key Metrics 2026-10-08
Doximity, Inc. (DOCS) is trading at $29.38, up 6.10% today (as of October 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $29.67 (1.0% upside).
- Volatility is moderate (37.55% annualized), implying notable price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (7.30% YoY) alongside competitive pressures in the Health Information Services space.
DOCS Stock Analysis: Key Metrics & Valuation (October 2026)
Concise, actionable data for investors
Doximity, Inc. - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $4.56B
P/E Ratio
Forward P/E: 17.24
Revenue Growth
Year over Year
Analyst Target
+1.0% upside potential
Key Investor Questions About DOCS
What investors need to know before buying
Based on current market data, DOCS presents a neutral technical setup with looking solid fundamentals.
- Technicals say: Neutral (RSI 67.94)
- Fundamentals say: Looking solid (debt and growth supportive)
DOCS's growth trajectory depends on its ability to expand within the Health Information Services sector while managing margin pressures.
- Future growth will depend on performance in core Health Information Services operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for DOCS investors include debt exposure and competitive dynamics in the Health Information Services industry.
- $9.67M in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Health Information Services.
52-Week Trading Range
Over the past year, DOCS stock traded between $17.15 and $74.33 and currently trades in the middle of that range. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 37.55% annualized volatility and β=0.83, the stock exhibits low sensitivity to market moves—making DOCS suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
Lower institutional support combined with high short selling points to negative sentiment.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Can Doximity Keep Shrinking Its Share Count Through Its AI Investment Year?
Doximity (DOCS), which calls itself the leading digital platform for U.S. medical professionals, has seen its stock fall steeply over the past year. Even after a rise over the past three months, the shares sit about 65% below their 52-week high. Management continued its repurchase program, allocating approximately $401 million over the latest twelve months. The test is whether it can keep that up through what it calls its AI investment year.
What Doximity (DOCS)'s Bedside Bench AI Benchmark Launch Means For Shareholders
Doximity recently launched Bedside Bench, an open-source benchmark designed to evaluate clinical-grade AI using realistic bedside scenarios, and independent testing by Fireworks ranked its Doximity Ask system ahead of several frontier models. This move highlights how domain-specific, healthcare-focused AI can outperform general-purpose systems on clinically relevant tasks, potentially strengthening Doximity’s positioning as a trusted tool for physicians. We’ll now examine how Doximity’s...
Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing
In the closing of the recent trading day, Doximity (DOCS) stood at $26.84, denoting a +2.8% move from the preceding trading day.
Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note
Doximity (DOCS) closed at $25.81 in the latest trading session, marking a -2.2% move from the prior day.
Doximity’s ex-chief revenue officer to pay nearly $500K to SEC: Trial Balance
Paul Jorgensen has been ordered to pay the sum in the wake of allegations of insider trading.
Doximity’s ex-chief revenue officer to pay nearly $500K to SEC: Trial Balance
Paul Jorgensen has been ordered to pay the sum in the wake of allegations of insider trading.
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
3 Reasons to Avoid DOCS and 1 Stock to Buy Instead
Since March 2026, Doximity has been in a holding pattern, posting a small return of 2.8% while floating around $26.41. The stock also fell short of the S&P 500’s 12.1% gain during that period.
Amplitude, GitLab, Doximity, Freshworks, and Sprinklr Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after quarterly earnings and upbeat corporate commentary signaled that artificial intelligence is driving growth across enterprise software rather than threatening legacy business models.
1 Software Stock on Our Buy List and 2 Facing Challenges
Software is eating the world, and virtually no business is left untouched by it. Companies bringing it to life have been rewarded with explosive earnings growth, and the upward trend shows no signs of stopping as the industry has posted a 44.6% gain over the past six months, beating the S&P 500 by 32.9 percentage points.
Explore More Analysis for DOCS
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
Next report Nov 5, 2026 (after the close, usually)
Frequently Asked Questions
Common investor questions about Doximity, Inc.
Doximity, Inc. (DOCS) is currently trading at $29.38. The RSI (14-day) is at 67.9, indicating neutral territory. Wall Street analysts have a consensus "hold" recommendation. The mean analyst price target of $29.67 implies 1.0% upside from current levels. Volatility is moderate at 37.6% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Doximity, Inc. (DOCS): The trailing P/E ratio is 31.42, which is above the market average, indicating investors are pricing in higher growth expectations. The forward P/E is 17.24, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 0.59, below 1.0, which generally indicates the stock is undervalued relative to its growth rate. Price-to-Book is 5.18. Price-to-Sales is 5.13. Valuation should be compared to Health Information Services industry peers for context, as different sectors trade at different multiples.
Based on 18 analysts covering DOCS, the consensus price target is $29.67. This represents a 1.0% upside from the current price of $29.38. The range spans from a low target of $18.00 to a high target of $47.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "hold". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Doximity, Inc. (DOCS) does not currently pay a regular dividend. The company may be reinvesting profits into growth initiatives, or may not yet be profitable enough to distribute earnings to shareholders.
Key risks for Doximity, Inc. (DOCS) investors include: 1. Moderate volatility (37.6% annualized)—price swings are notable. 2. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 3. Health Information Services sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Doximity, Inc.'s (DOCS) current debt and financial health profile: Total debt stands at $9.67M. The debt-to-equity ratio is 0.01x, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 6.08, indicating strong short-term liquidity. The quick ratio is 5.80. The company holds $687.79M in cash and equivalents. Free cash flow is positive at $239.70M, providing a cushion for debt servicing and shareholder returns.